Gaithersburg-based biotech MedImmune has appointed Yong-Jun Liu, chief scientific officer of the Baylor Research Institute, as its new head of research.
The appointment puts Liu in a pivotal role, not just for MedImmune but also for its parent company, AstraZeneca, which is depending on its U.S.-based biologics arm to supply a pipeline of early-stage drug candidates.